Chandigarh

Financial BO

Goods

Medicines

Human Anti-haemophilic Factor VIII recombinant (monoclonal purified nanofilter) 1500 IU

Government Medical College and Hospital

GMCH Sector 32 Chandigarh | Chandigarh

Amount: Refer DocsCloses: 3 Jan 2024Closed

Timeline

Published14 Dec 2023
Closed3 Jan 2024
Technical Evaluation12 Feb 2024
Financial Evaluation13 Feb 2024
Award—

Bids

2 Bids13 Feb 2024

#	Company	Status
1	Novo Nordisk India Private Limited Admitted-Finance 1ST AND 2ND FLOOR NXT TOWER 2 EMBASSY MANYATA BUSINESS PARK NAGAVARA VILLAGE KASABA HOBLI BANGALORE KARNATAKA INDIA 560045 \| BANGALORE \| BANGALORE \| KARNATAKA \| 560045	Admitted-Finance
2	Takeda Biopharmaceuticals India Private Limited Admitted-Finance 6TH FLOOR BUILDING NO 8 TOWER C DLF CYBER CITY PHASE II MOTI NAGAR GURGAON WEST DELHI DELHI 122002 \| GURUGRAM \| HARYANA \| 122002	Admitted-Finance

Tender Value

Refer Docs

EMD Value

₹1.1 L

Closing Date

3 Jan 2024, 2:00 pmClosed

Tender Inviting Organisation

Name

Director Principal

Address

GMCH Sector 32 Chandigarh

Work Description

Human Anti-haemophilic Factor VIII recombinant (monoclonal purified nanofilter) 1500 IU

Tender Information

Tender ID

2023_GMCH_77610_1

Reference Number

GMCH/PH-PRO/528-MED/2023

Tender Type

Open Tender

Product Category

Medicines

Form of Contract

Item Rate

Period of Work

40 days

Location

GMCH Sector 32 Chandigarh

Source Website

Subscribe to view

Eligibility / Pre-Qualification

Please refer tender document

Documents Required

12 documents required · 12 mandatory

Fee

RequiredEMD (.pdf)

PreQual/Technical

RequiredComplete specification with packing detail need to be mentioned by supplier (.pdf)

RequiredManufacturing License from Principal Manufacturer (.pdf)

RequiredGMP Certificate under Schedule M/revised Schedule M of Drug Cosmetic Act or WHOGMP from manufacturer (.pdf)

RequiredIf rates are quoted by the distributor/sister concern/ dealer then authority letter should be submit (.pdf)

RequiredAffidavit in prescribed performa regarding non-blacklisting of firm from Principal Manufacturer (.pdf)

RequiredList of buyers to whom you have supplied drug (min 100 bedded hospitals) from Principal Manufacturer (.pdf)

RequiredNo.of yrs standing of firm in drug manufacturing sector(required min3yrs)from Principal manufacturer (.pdf)

RequiredUndertaking to be submitted that no mishap has been reported from any of item manufactured by firm (.pdf)

RequiredAnnual turn over of min last 3 yrs duly certified by C.A. (min 1 crore) from Principal manufacturer (.pdf)

RequiredValidity of rates and rate certificate (.pdf)

Finance

RequiredPRICE BID (.xls)

Fee & Financial Details

Tender Fee Amount

₹0

EMD Fee Amount

₹1.1 L

Important Dates

Last Activity

13 Feb 2024

Published

14 Dec 2023

Bid Opening

4 Jan 2024

Download Starts

14 Dec 2023

Download Ends

3 Jan 2024

Submission Starts

14 Dec 2023

Stage Documents

Stage Summary Snapshot

stage.html

html • 0.02 MB

Technical Evaluation

tech_eval.pdf

PDF

Documents

Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.

Tender Page Snapshot

details.html

html • 0.03 MB

Ready to Participate?

Download all tender documents and submit your bid

Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .

Loading…

Company

Novo Nordisk India Private Limited

Admitted-Finance

1ST AND 2ND FLOOR NXT TOWER 2 EMBASSY MANYATA BUSINESS PARK NAGAVARA VILLAGE KASABA HOBLI BANGALORE KARNATAKA INDIA 560045 | BANGALORE | BANGALORE | KARNATAKA | 560045

Takeda Biopharmaceuticals India Private Limited

Admitted-Finance

6TH FLOOR BUILDING NO 8 TOWER C DLF CYBER CITY PHASE II MOTI NAGAR GURGAON WEST DELHI DELHI 122002 | GURUGRAM | HARYANA | 122002